Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.
The Link Between Manufacturing and Commercialization in Gene and Cell Therapies
The highly customized nature of cell and gene therapy production means that manufacturing innovations for one therapy may not be easily transferable to others.
The Link Between Manufacturing and Commercialization in Gene and Cell Therapy
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.